CareDx, Inc. · 4 hours ago
Medical Science Liaison - Cell Therapy & Transplant
United States
Full-time
Remote
Mid, Senior Level
$110K/yr - $170K/yr
3+ years expCareDx, Inc. is a leading precision medicine solutions company focused on the discovery, development, and commercialization of healthcare solutions for transplant patients. The Medical Science Liaison (MSL) for Cell Therapy & Transplant will collaborate with the Medical Director and stakeholders to support clinical studies and engage with key opinion leaders in the field.
BiotechnologyHealth CareHealth DiagnosticsInformation Technology
Responsibilities
Support CareDx sponsored clinical trial(s) alongside clinical operations
Develop strong and productive working relationships with key opinion leaders (KOLs) in the field of bone marrow transplantation and cell therapy to introduce CareDx, share recent data readouts and to gather market insights
Partner with medical director and biostats team in writing and submitting abstracts and publications to highlight test performance and clinical utility
Help to identify and support investigator-initiated studies in support of company research priorities
Communicate existing unmet clinical needs and how CareDx in development products will help to meet these needs
Help analyze, interpret, and clarify test results of commercially available CTT tests in conjunction with other clinical data
Assist new product development in defining unmet needs, product performance requirements, and launch plans
Provide clinical support for Customer Service inquiries and complaints
Participate in Advisory Board meetings with KOLs
Support company initiatives at clinical and scientific meetings
Function as a clinical liaison and resource to payer and insurance groups
Qualification
Required
Health care professionals with relevant clinical sciences knowledge in oncology will be considered: Pharm D, PhD, or MD
Prior experience in MSL role preferred and/or the introduction of new clinical laboratory tests preferred
3-5 plus years of work experience in bone marrow transplantation and/or oncology
Experience in collaborating with research staff and key opinion leaders on clinical trials (sponsored and investigator initiated)
Knowledge of Good Clinical Practice (GCP) guidelines is a plus
Experience in drafting impactful case studies, conference abstracts/ posters and publications
Outstanding oral presentation skills including ability to clearly present clinical data and address clinical & scientific questions related to CareDx CTT products
Experience in establishing strong, collaborative working relationships with clinicians and with internal stakeholder functions (e.g. Sales, Marketing, Regulatory, R&D) and external customers
Knowledge of molecular biology and immunology helpful
Outstanding interpersonal skills and collaborative work style
This is a remote based role with preference to those living in central or west coast US. Significant travel will be required (up to 50%)
Benefits
Competitive base salary and incentive compensation
Health and welfare benefits, including a gym reimbursement program
401(k) savings plan match
Employee Stock Purchase Plan
Pre-tax commuter benefits
Living Donor Employee Recovery Policy that allows up to 30 days of paid leave annually to a full-time employee who makes the selfless act of donating an organ or bone marrow.
Company
CareDx, Inc.
CareDx, Inc., headquartered in South San Francisco, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers.
501-1000 employees
H1B Sponsorship
CareDx, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (16)
2024 (8)
2023 (4)
2022 (22)
2021 (21)
2020 (9)
Funding
Current Stage
Public CompanyTotal Funding
$574.89MKey Investors
Bristol-Myers SquibbSprout Group
2021-01-21Post Ipo Equity· $164M
2020-06-09Post Ipo Equity· $117.1M
2018-11-13Post Ipo Equity· $52.8M
Leadership Team
John Hanna
President and CEO
Nathan Smith
Chief Financial Officer
Recent News
2026-01-16
2026-01-14
Company data provided by crunchbase